29 Sep Mirai Bio
Kate Torchilin, CEO, Mirai Bio; CEO-Partner, Flagship Pioneering
Oct. 6 | 4:30pm | FLW Ballroom F
Cambridge, MA
(Private)
Mirai Bio is delivering genetic medicines from promise to performance. Founded by Flagship Pioneering, Mirai was built to solve one of the field’s central challenges: achieving precise, scalable delivery of diverse nucleic acid payloads to cells and tissues beyond the liver. By combining novel lipid chemistries, a large and growing proprietary in vivo biodistribution dataset, machine learning-guided lipid nanoparticle optimization, modular targeted particle design, and manufacturability, Mirai helps partners accelerate development, reduce technical risk, and pursue high-value programs making tissue and cell type specific delivery a strategic advantage. Private